Pilot Study to Assess the Efficacy of Botulinum Toxin B on Pain and Disability in Subjects With Acute Low Back Pain

NCT00384579 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

FED

Sponsor class

Stopped No eligible candidates in 2 years of recruiting

Conditions

Low Back Pain

Interventions

DRUG: Botulinum toxin B
DRUG: Placebo

Sponsor

United States Department of Defense